Humacyte, Inc. Warrants (HUMAW)
NGS · Warrant · CUSIP 44486Q111
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for HUMAW and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
44486Q111 (prev. 020751111 )
Previous Symbol
AHACW (changed 8/27/2021)
Parent Company
Alpha Healthcare Acquisition Corp (HUMA)
Business: Humacyte, Inc. develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte’s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease.
Notes: Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment

Company Contact

CEO
Laura E. Niklason
CFO
Dale Sander
Headquarters
2525 East North Carolina Highway 54, Durham NC 27713
Phone
919-313-9633
Investor Relations
919-313-9633 · investors@humacyte.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »